Glutamic Acid.

Glutamate decarboxylase converts glutamate to GABA using pyridoxal-5-phosphate as its cofactor, and the same cofactor drives the transaminases that move glutamate's nitrogen. Without active B6 the glutamate pool is not redirected.

GABA is made from glutamate in a single decarboxylation step, and it is recycled back to glutamate by GABA transaminase. The two sit at opposite ends of one short loop.

Glutamine synthetase adds ammonia to glutamate and glutaminase takes it off again, so the two amino acids are one reaction apart. Tissues shuttle between them constantly to move nitrogen safely.

Glutathione is a tripeptide of glutamate, cysteine and glycine, and glycine is added in the second synthesis step. Supplying glutamate without glycine leaves that step short.

Glutamate and cysteine are joined first by glutamate-cysteine ligase, and cysteine availability is normally what limits the reaction. NAC supplies that cysteine while glutamate covers the other half of the bond.

Glutamine synthetase requires manganese at its active site to attach ammonia onto glutamate. Manganese status therefore governs how quickly glutamate is converted for nitrogen transport.

At resting membrane potential a magnesium ion sits inside the NMDA receptor channel and physically blocks ion flow until the cell depolarises. That block is the standing brake on glutamate signalling.

Theanine is a glutamate analogue that occupies glutamate transporters and binds weakly at glutamate receptor sites. It therefore modulates the same signalling glutamate drives rather than adding to it.

Glutamate dehydrogenase and the transaminases interconvert glutamate and alpha-ketoglutarate, so alpha-ketoglutarate is glutamate without its amino group. Supplying one feeds the other directly.

Zinc is released alongside glutamate at certain synapses and binds an allosteric site on the NMDA receptor that damps the response. It is part of the normal control on glutamate signalling.

Arginine glutamate delivers the glutamate anion paired with arginine, so the two supply the same amino acid. The pairing also links glutamate nitrogen to the urea cycle through arginine.

Glutathione is built from glutamate, cysteine and glycine, and the first step is glutamate cysteine ligase joining glutamate to cysteine. Glutamate supply is rarely the limiting input in a fed adult, since cysteine usually is. The relationship is a settled pathway rather than a supplementation result, so it describes chemistry and not an outcome.

Glutamate and cysteine are condensed by glutamate cysteine ligase into gamma-glutamylcysteine, the committed intermediate of glutathione synthesis. Cysteine is the input that most often runs short, so the two are described together in every account of the pathway. This is pathway mapping, not a claim that the pair changes a measured endpoint.

Proline is made from glutamate through glutamate-5-semialdehyde and pyrroline-5-carboxylate. The same intermediate also feeds ornithine, which is why glutamate sits upstream of both proline and the urea cycle. Read it as mechanistic rather than clinical.

Glutamate is the carbon donor for ornithine and the substrate for N-acetylglutamate, the obligatory allosteric activator of carbamoyl phosphate synthetase 1. Arginine in turn stimulates N-acetylglutamate synthase, so the two nutrients meet at the top of the urea cycle. The link is textbook nitrogen handling and carries no dosing implication on its own.

Ornithine aminotransferase interconverts ornithine and glutamate semialdehyde, placing the two amino acids one enzymatic step apart. Which direction the reaction runs depends on tissue and nitrogen load. It is a reversible pathway relationship, not a demonstrated combination effect.

Carbon leaving glutamate as alpha-ketoglutarate is oxidised by the alpha-ketoglutarate dehydrogenase complex, which needs thiamine pyrophosphate. Without that cofactor the carbon backs up before the succinyl-CoA step. This is a cofactor requirement of the pathway, not evidence that taking the two together changes anything measurable.

Glutamate dehydrogenase uses NAD or NADP as the electron acceptor when it deaminates glutamate to alpha-ketoglutarate. Redox state therefore sets which direction the reaction favours. The pairing is a cofactor relationship and describes flux, not a supplement outcome.

Folylpolyglutamate synthase adds a chain of glutamate residues to folate, and that tail is what retains folate inside the cell and raises its affinity for one-carbon enzymes. Intestinal absorption runs the other way, with a brush-border hydrolase stripping the glutamates first. Glutamate is structural here rather than dose-limiting.

Excitatory amino acid transporters move glutamate against its gradient by co-transporting sodium ions and counter-transporting potassium. The sodium gradient set by the sodium-potassium pump is what powers glutamate clearance from extracellular space. This is transport physiology and it applies to endogenous glutamate as much as to any taken by mouth.

Aspartate aminotransferase swaps the amino group between glutamate and oxaloacetate, producing aspartate and alpha-ketoglutarate. The pair therefore shares one enzyme and one nitrogen pool, and the malate-aspartate shuttle depends on that exchange. Aspartate is among the most frequent co-mentions of glutamate in the indexed literature.

Taurine and glutamate are both abundant free amino acids in muscle and brain and both act on chloride-permeable and excitatory signalling in opposite directions. Formulators list them together in amino acid blends for that reason. The pairing is described mechanistically and has not been isolated as a combination in human work available here.